期刊文献+

临床药师参与1例新型隐球菌性脑膜炎抗真菌治疗的病例分析 被引量:7

Case Analysis of the Participation of Clinical Pharmacist in Antifungal Drug Treatment of New Type Cryptococcal Meningitis
原文传递
导出
摘要 目的:探讨临床药师在新型隐球菌性脑膜炎患者抗真菌治疗中的药学服务方法。方法:临床药师参与1例新型隐球菌性脑膜炎患者的药物治疗过程,从协助医师优化抗真菌药物治疗方案、对患者进行药学监护、不良反应处理及用药教育等方面提供药学服务。使用两性霉素B期间,患者出现顽固性低钾血症,临床药师建议医师降低两性霉素B剂量,加用伏立康唑抗真菌治疗。结果:调整抗真菌治疗方案后,患者未再出现低血钾;经系统抗真菌治疗11周后,患者病情较前明显好转。结论:临床药师参与新型隐球菌性脑膜炎抗真菌治疗的心得是:遵循指南,但不失灵活处理;主动服务,细节保障用药安全。 OBJECTIVE: To explore the method of pharmaceutical care for antifungal drug treatment of new type crypto- coccal meningitis by clinical pharmacist. METHODS: Clinical pharmacist participated in the drug treatment process for a pa- tient with new type cryptococcal meningitis. Clinical pharmacist provided pharmaceutical care in following aspects: assisting doctor to optimize antifungal drugs treatment plan, providing patients pharmaceutical monitoring and medication education, etc. During amphotericin B treatment, the patient developed refractory hypokalemia. Clinical pharmacists suggested doctors to reduce the dose of amphotericin B and additionally use voriconazole for antifungal treatment. RESULTS: The patient devel- oped refractory hypokalemia no more after the plan was adjusted. After 11 weeks of systematic antifungal treatment, the pa- tient was on the mend. CONCLUSIONS: The participation of clinical pharmacist in antifungal treatment of new type cryptococ- cal meningitis indicates that following the instructions, but not lost flexible disposal; providing service actively, and details is guarantee of safety.
作者 孙闻续 徐珽
出处 《中国药房》 CAS 北大核心 2015年第20期2854-2857,共4页 China Pharmacy
关键词 临床药师 新型隐球菌性脑膜炎 抗真菌药 药学监护 Clinical pharmacist New type cryptococcal meningitis Antifungal drugs Pharmaceutical care
  • 相关文献

参考文献11

  • 1陈灏珠,林果为.实用内科学[M].13版.北京:人民卫生出版社,2009:919.
  • 2许绍强,陈玲玲,姜楠,肖海华,周小坚.隐球菌性脑膜炎的脑脊液检查结果分析[J].国际检验医学杂志,2014,35(5):632-634. 被引量:7
  • 3Park B J, Wannemuehler KA, Marston B J, et al.Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.[J]. AIDS, 2009,23 (4):525.
  • 4Perfect JR, Dismukes WE, Dromer F, et al. Clinical prac- tice guidelines for the management of cryptococcal dis- ease: 2010 update by the infectious disease society of America[J]. Clin Infect Dis, 2010,50 (3) : 291.
  • 5Shoji H, Takuma T, Ohbayashi H, et al. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococ- cal meningoencephalitis[J]. J Infect Chemother, 2012, 18 (5) : 775.
  • 6沈银忠,卢洪洲,齐唐凯,江雪艳,张仁芳,郑毓芳,刘莉,王江蓉.两性霉素B联合氟胞嘧啶与伏立康唑治疗艾滋病合并隐球菌脑膜炎的临床回顾性研究[J].中国真菌学杂志,2009,4(6):338-342. 被引量:18
  • 7Loyse A, Wilson D, Meintjes G, et al. Comparison of the early fungicidal activity of high-dose fluconazole, vori- conazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis[J]. Clin lnfect Dis,2012,54(1) : 121.
  • 8Usami E, Kimura M, Kanematsu T, et al. Evaluation of hy- pokalemia and potassitm supplementation during admin- istration of liposomal-amphotericin B[J]. Exp Ther Med, 2014,7(4):941.
  • 9Karimzadeh I, Khalili H, Dashti-Khavidaki S, et al. N-ace- tyl cysteine in prevention of amphotericin-induced electro- lytes imbalances: a randomized, double-blinded, place- bo-controlled, clinical trial[J]. Eur J Clin Pharmacol, 2014,70(4) : 399.
  • 10王威,帅琴燕,李彤.安体舒通对两性霉素B脂质体致低钾血症的预防作用[J].中华危重症医学杂志(电子版),2008,1(2):33-34. 被引量:2

二级参考文献20

共引文献963

同被引文献43

  • 1赵荣生,严宝霞,侯新朴.两性霉素B脂质体体内外毒性及抗真菌活性的研究[J].中国抗生素杂志,2001,26(2):123-126. 被引量:15
  • 2Costa ML, Souza JP, Oliveira Neto AF, et al. Cryptococcal meningitis in HIV negative pregnant women : case report and review of literature Rev[ J ]. lust Med Trop S Paulo, 2009,51 (5) : 289-294.
  • 3Ely EW, Peacock JEF, Haponit EF, et al. Cryptococcal pneumonia complicating pregnancy[ J]. Medicine, 1998,77 (3) : 153-167.
  • 4Vawda F, Maharaih J, Naidoo K. Massive cryptococcal lymphadenopa- thy in an immunocompetent pregnant patient [ J ]. Brj Radiol,2008,81 (962) : e53-56.
  • 5Nakamura S, Lzumikawa K, Seki M, et al. Pulmonary cryptococcosis in late pregnancy and review of published literature[ J]. Mycopatholo- gia ,2009,167 ( 3 ) : 125-131.
  • 6Catanzaro A. Pulmonary mycosis in pregnant women [ J]. Chest, 1984, 86(3 Suppt) :14S-18S.
  • 7Feldman R. Cryptococcosis ( torulosis ) of the central nervous system treated with amphotericin B during pregnancy [ J ]. South Med J, 1959, 52 : 1415-1417.
  • 8Peterson CM, Schuppert K, Kelly PC, et al. Coccidioidomycosis and pregnancy[ J]. Obstet Gynecol Surv, 1993,48 : 149-156.
  • 9Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guide- lines for the management of cryptococcal disease:2010 update by the infectious disease society of America [ J]. Clin Infect Dis, 2010,50 (3) :291-322.
  • 10Goodwin SD, Cleary JD, Walawander CA, et al. Pretreatment regi- mens for adverse events related to infusion of amphotericin B [ J ]. Clin Infect Dis, 1995,20:755-761.

引证文献7

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部